Ros Matthew 4
4 · Cogent Biosciences, Inc. · Filed Oct 5, 2021
Insider Transaction Report
Form 4
Ros Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-10-01$5.03/sh+2,463$12,393→ 2,463 totalExercise: $8.54Exp: 2031-10-01→ Common Stock (2,463 underlying)
Footnotes (2)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
- [F2]This option is fully vested at time of grant.